日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Single-cell and spatial transcriptome analyses reveal MAZ(+) NPC-like clusters as key role contributing to glioma recurrence and drug resistance

单细胞和空间转录组分析揭示,MAZ(+) NPC样细胞簇在胶质瘤复发和耐药性中发挥关键作用。

Qiang Gu,Kan Wang,Tingming Lu,Yifei Xiao,Yaqing Wu,Hang Zhou,Kaijia Zhou

Single-Cell RNA Sequencing Reveals Potential Mechanism of RUNX3 Reshaping Tumor Microenvironment in Non-small-cell Lung Cancer.

单细胞 RNA 测序揭示 RUNX3 重塑非小细胞肺癌肿瘤微环境的潜在机制。

Xiao Weijin, Zheng Jianqing, Deng Yujie, Huang Bifen, Liu Weibin, Zheng Xuejin, Zhou Kaijia, Fang Weimin, Chen Xiaohui

Chinese Expert Consensus on Leptomeningeal Metastases of Lung Cancer

中国专家对肺癌软脑膜转移的共识

Lin, Gen; Wang, Yongsheng; Xin, Tao; Zhang, Ding; Zhang, Qiuyu; Li, Yangsi; Chi, Yudan; Fan, Yun; Liu, Anwen; Xu, Haipeng; Shi, Liang; Zhang, Longfeng; Miao, Qian; Zheng, Xiaobin; Li, Lijun; Zhou, Kaijia; Yao, Qiwei; Zou, Zihua; Miao, Kang; Hong, Yaping

FXYD2 mRNA expression represents a new independent factor that affects survival of glioma patients and predicts chemosensitivity of patients to temozolomide

FXYD2 mRNA表达是影响胶质瘤患者生存率并预测患者对替莫唑胺化疗敏感性的一个新的独立因素。

Zhou, Kaijia; Jiang, Tao; Liu, Yanwei; Zhao, Zheng; Huang, Lijie; Li, Guanzhang

A new glioma grading model based on histopathology and Bone Morphogenetic Protein 2 mRNA expression

基于组织病理学和骨形态发生蛋白2 mRNA表达的新型胶质瘤分级模型

Zhou, Kaijia; Zhao, Zheng; Li, Shouwei; Liu, Yanwei; Li, Guanzhang; Jiang, Tao